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###### 

Bone markers, BMD, 25(OH)D and TDF use

                                                                            a\) All patients                                   b\) 25(OH)D\<50 nmol/L   
  --------------------------------------------------- --------------------- --------------------- ------ --------------------- ------------------------ ------
  PTH, ng/L, median (IQR)                             48 (36, 55)           51 (39, 65)           0.54   46 (36, 64)           47 (38, 62)              0.55
  Lumbar spine BMD, g/cm^2^, mean (SD)                1.131 (0.146)         1.149 (0.174)         0.41   1.130 (0.153)         1.156 (0.176)            0.32
  Non-dominant total hip BMD, g/cm^2^, mean (SD)      0.995 (0.133)         0.986 (0.144)         0.61   0.989 (0.140)         0.997 (0.151)            0.76
  Non-dominant femoral neck BMD, g/cm^2^, mean (SD)   0.944 (0.124)         0.945 (0.180)         0.96   0.940 (0.129)         0.935 (0.137)            0.83
  P1NP, ng/mL, median (IQR)                           13.61 (5.55, 32.37)   10.95 (5.52, 24.83)   0.52   14.49 (5.83, 40.68)   12.66 (6.48, 23.95)      0.60
  CTX, ng/mL, median (IQR)                            1.94 (0.85, 4.84)     2.39 (1.02, 5.33)     0.29   2.02 (1.03, 4.84)     2.48 (1.17, 5.65)        0.32
